CORE PRESCRIBING SOLUTIONS LTD

Company number 12331551 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Credit Analysis: CORE PRESCRIBING SOLUTIONS LTD

1. Credit Opinion: APPROVE

Reasoning: This company demonstrates exceptional financial strength with £2.25M cash reserves against total liabilities of just £617K, yielding a current ratio of 5.18x. Net assets have grown consistently from £18K at incorporation (2019) to £2.6M by November 2025, indicating sustained profitable trading. The business operates in a resilient sector (NHS primary care support services) and carries negligible leverage. No adverse conduct records exist against any of the three director-shareholders. The credit risk is low, and the company possesses ample capacity to service debt obligations.


2. Financial Strength

Balance Sheet Summary (Year Ending 30 November 2025)

Metric 2025 2024 YoY Change
Total Assets £3,248,404 £3,420,964 -5.0%
Net Assets £2,618,259 £2,439,012 +7.4%
Cash £2,246,757 £2,031,403 +10.6%
Net Current Assets £2,577,104 £2,389,104 +7.9%
Shareholders' Funds £2,618,259 £2,439,012 +7.4%

Key Observations:

  • Net Asset Growth: Consistent and impressive trajectory from £18K (2020) to £2.6M (2025). Retained profits for FY2025 of approximately £179K demonstrate ongoing profitability, though this represents a deceleration from prior year growth rates.

  • Cash Dominance: Cash represents 69.2% of total assets (£2.25M of £3.25M). This provides exceptional liquidity but may indicate under-deployment of capital. The business is conservatively managed.

  • Modest Fixed Assets: Only £54K in fixed assets (intangibles £38K, tangibles £16K), reflecting an asset-light service business model. Capitalised development costs of £11.8K added in-year suggest ongoing investment in systems/processes.

  • Liability Reduction: Total liabilities decreased by 37.2% from £982K to £617K, driven primarily by a significant reduction in corporation tax payable (from £480K to £34K) and lower other debtors. Trade creditors remain relatively stable at £375K.

  • Provisions: A new provision of £13K appears in 2025 (absent in 2024). This is immaterial but warrants brief clarification.

Leverage Position: Total liabilities represent just 23.6% of net assets. There is no long-term debt on the balance sheet. The company is effectively debt-free, providing substantial headroom for additional borrowings.


3. Cash Flow Assessment

Liquidity Analysis

Metric 2025 2024
Current Ratio 5.18x 3.43x
Cash as % of Current Assets 70.3% 60.3%
Trade Debtors £692,339 £643,348
Trade Creditors £374,593 £401,595
Working Capital £2,577,104 £2,389,104

Working Capital Assessment: Exceptional. Net current assets of £2.58M provide a substantial buffer. The current ratio of 5.18x significantly exceeds prudent thresholds (typically 1.5-2.0x for service businesses).

Debtor Analysis: Trade debtors increased modestly by £49K (7.6%) year-on-year. With 21 employees and the nature of NHS-related contracts, debtor days should be monitored but appear manageable. The significant reduction in total debtors (from £1.34M to £947K) is driven by a £441K decrease in "other debtors" rather than trade collections—this likely represents the resolution of a one-off item (possibly a tax-related asset given the £82K corporation tax recoverable remains constant).

Creditor Position: Trade creditors decreased slightly from £402K to £375K, suggesting stable supplier payment practices. No trade creditor aging is provided, but the quantum relative to cash reserves presents no concern.

Director Loan Accounts: The three directors maintain loan accounts totalling £120K (name shown to subscribers: £41K, name shown to subscribers: £38K, name shown to subscribers: £41K). Net advances during the year were £10K (£575K advanced, £565K repaid). These appear to be amounts owed TO the directors (creditor position), representing additional capital injected. This demonstrates personal financial commitment from the shareholders but also indicates some financial intermingling that should be documented in any facility agreement.

Cash Generation: Cash increased by £215K during the year, from £2.03M to £2.25M. This organic cash generation, combined with retained profits, confirms the business is self-funding and generating positive operating cash flows.


4. Monitoring Points

Critical Metrics to Watch:

  1. Revenue Sustainability & NHS Contract Dependency: The business operates in primary care support services, which is heavily NHS-dependent. While NHS funding is relatively stable, contract renewal risk and changes to Primary Care Network (PCN) funding structures could materially impact revenue. Request visibility on contract durations, renewal dates, and client concentration.

  2. Profitability Trajectory: Net assets grew by £179K in FY2025 versus £1.0M in FY2024 (though the prior year likely included significant accumulated profits). The corporation tax provision dropped dramatically from £480K to £34K, which could indicate either lower profitability in FY2025 or timing of tax payments. Request management accounts to confirm current-year trading performance.

  3. Growth Management: Headcount increased from 17 to 21 employees (23.5% growth). Rapid headcount growth in service businesses can strain working capital and operational quality. Monitor staff costs relative to revenue to ensure margins are maintained.

  4. Director Loan Account Movements: The directors advance and repay significant sums (£575K advanced, £565K repaid in-year). Any facility should include covenants restricting further director loans or requiring subordination of existing director loan balances.

  5. Cash Utilisation Strategy: With £2.25M in cash, the business may be planning significant investment (acquisition, premises, or expansion). Understand capital expenditure plans and whether any contingent commitments exist.

  6. Other Debtors Resolution: The £441K reduction in other debtors year-on-year should be understood. If this represented a one-off asset, it may not recur, and future balance sheets will reflect a more normalised position.

  7. Provision Nature: The £13K provision is new and unexplained. Clarify whether this represents an operational, legal, or contractual obligation.

Suggested Covenant Structure (if lending):

  • Minimum net assets: £2.0M
  • Maximum leverage: 30% (total liabilities/total assets)
  • Current ratio minimum: 2.0x
  • Restriction on director withdrawals exceeding £50K without lender consent
  • Negative pledge on fixed assets
  • Notification of NHS contract losses exceeding 20% of annual revenue

Names of the people mentioned are shown to subscribers. See subscription

Perspective: Business Credit Analyst · Model: glm-5.1 · Generated 9 September 2026